Why Tesla Motors, Solazyme, and VIVUS Plunged Today
The Dow hit a new record high, but Tesla Motors and Solazyme each dropped 15%, while VIVUS posted a 12% drop. Find out why these stocks didn't join in the market's bull run today.
The Good, Bad, and Ugly of VIVUS' Earnings
VIVUS continues to struggle to sell its obesity drug Qsymia. Investors in Arena Pharmaceuticals and Orexigen should take note.
Why Myriad, Curis, and VIVUS Could Pop or Drop Today
These four stocks could make big moves today. Let's check in on the headlines moving Myriad, Jazz, Curis, and VIVUS.